The CBO released a brief report looking at the potential impact of various changes in federal policies on research and development spending for drugs. Current and future policies are not…
Read More
Another summary of miscellaneous health care items, including telemedicine and prevention and wellness.
Read More
Another dose of weekend tidbits, covering PAP screenings, health insurer consolidation, Part D plan satisfaction, Rand's look at the best methods to reduce health care costs, geographic variations in health…
Read More
Interesting reports on specialty pharmacy, drug benefits, drug sales and the IMS buyout.
Read More